Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.48 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7312217 | 0.94 | MMEL1 (0.55) | MMEL1 | |
| SCHEMBL7310813 | 0.94 | MMEL1 (0.55) | MMEL1 | |
| SCHEMBL7309986 | 0.94 | MMEL1 (0.55) | MMEL1 | |
| SCHEMBL7314736 | 0.91 | MMEL1 (0.48) | MMEL1MMEACE | |
| SCHEMBL7340648 | 0.91 | MMEL1 (0.48) | MMEL1MMEACE | |
| SCHEMBL7314996 | 0.89 | MMEL1 (0.47) | MMEL1 | |
| SCHEMBL7311820 | 0.88 | MMEL1 (0.50) | MMEL1 | |
| SCHEMBL7320018 | 0.87 | MMEL1 (0.46) | MMEL1 | |
| SCHEMBL7318645 | 0.86 | MMEL1 (0.50) | MMEL1 | |
| SCHEMBL7318929 | 0.86 | MMEL1 (0.50) | MMEL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0511940-A2 | Phosphono/biaryl substituted dipeptide derivatives | CIBA-GEIGY AG (CH) | 1992-11-04 | — | — | EP | claimed |
| EP-0592367-A2 | Phosphono/biaryl substituted dipeptide derivatives | CIBA-GEIGY AG (CH) | 1994-04-13 | — | — | EP | disclosed |
| US-5294632-A | Diuretics and vasorelaxants | CIBA-GEIGY CORPORATION (US) | 1994-03-15 | — | — | US | disclosed |
| EP-0511940-A2 | Phosphono/biaryl substituted dipeptide derivatives | CIBA-GEIGY AG (CH) | 1992-11-04 | — | — | EP | disclosed |
| US-5155100-A | Treating cardiovascular disorders in mammals | CIBA-GEIGY CORPORATION (US) | 1992-10-13 | — | — | US | disclosed |